EBay Inc. (NASDAQ:EBAY) said on September 30 that it would separate its PayPal digital-payments unit and marketplace business into two companies by the end of next year. eBay Inc. (NASDAQ:EBAY) belongs to Services sector. Its net profit margin is -0.70% and weekly performance is -6.46%. On last trading day company shares ended up $52.97. eBay Inc. (NASDAQ:EBAY) distance from 50-day simple moving average (SMA50) is -1.08%.

Sunesis Pharmaceuticals (NASDAQ:SNSS) was downgraded by investment analysts at Roth Capital from a “buy” rating to a “neutral” rating in a note issued to investors on Tuesday,TheFlyOnTheWall.com reports. They currently have a $15.00 price objective on the stock. Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) shares fell -7.53% in last trading session and ended the day at $1.35. SNSS return on assets is -75.40%. Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) quarterly performance is -78.40%.

KBR, Inc. (NYSE:KBR) agreed to a deal with Algeria-based petrochemical firm Fertial SpA for licensing and engineering design services for a couple of its ammonia plants. The contract will be recorded in the third-quarter 2014 bookings of the company’s Hydrocarbons segment. The company closed at $18.42, moved down -1.92%, on volume of over 2.21M shares. The share price fell -3.86% in the last 5 days. The company has an average trading volume of 1.36M shares. Its market capitalization was $2.73B. On 07 October, KBR, Inc. (NYSE:KBR) shares fell -1.92% and was closed at $18.42. KBR EPS growth in last 5 year was -22.90%. KBR, Inc. (NYSE:KBR) year to date (YTD) performance is -41.67%.

Tenet Healthcare Corp. (NYSE:THC), the for-profit corporation poised to buy Eastern Connecticut Health Network, is facing labor trouble at a Massachusetts hospital it owns while preparing to close a facility in Michigan and lay off as many as 127 employees. Tenet Healthcare Corp. (NYSE:THC) ended the last trading day at $57.03. Company weekly volatility is calculated as 3.49% and price to cash ratio as 13.75. Tenet Healthcare Corp. (NYSE:THC) showed a weekly performance of -3.97%.

Keryx Biopharmaceuticals (NASDAQ:KERX) CFO James F. Oliviero III sold 2,694 shares of the stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $16.14, for a total transaction of $43,481.16. Following the sale, the chief financial officer now directly owns 153,345 shares of the company’s stock, valued at approximately $2,474,988. Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) shares fell -3.98% in last trading session and ended the day at $15.68. KERX return on assets is -63.10%. Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) quarterly performance is 2.62%.